
ICU Medical, Inc. – NASDAQ:ICUI
ICU Medical stock price today
ICU Medical stock price monthly change
ICU Medical stock price quarterly change
ICU Medical stock price yearly change
ICU Medical key metrics
Market Cap | 3.74B |
Enterprise value | 5.73B |
P/E | -55.83 |
EV/Sales | 2.51 |
EV/EBITDA | 30.62 |
Price/Sales | 1.84 |
Price/Book | 2.01 |
PEG ratio | 0.23 |
EPS | -2.45 |
Revenue | 2.25B |
EBITDA | 241.12M |
Income | -59.31M |
Revenue Q/Q | -0.47% |
Revenue Y/Y | -2.12% |
Profit margin | -3.26% |
Oper. margin | -0.16% |
Gross margin | 30.6% |
EBIT margin | -0.16% |
EBITDA margin | 10.69% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeICU Medical stock price history
ICU Medical stock forecast
ICU Medical financial statements
$190.5
Potential upside: 53.92%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 549.31M | -9.93M | -1.81% |
---|---|---|---|
Sep 2023 | 553.31M | 7.23M | 1.31% |
Dec 2023 | 587.98M | -17.14M | -2.92% |
Mar 2024 | 565.95M | -39.47M | -6.97% |
Jun 2023 | 4463044000 | 2.34B | 52.61% |
---|---|---|---|
Sep 2023 | 4376864000 | 2.27B | 52.06% |
Dec 2023 | 4378439000 | 2.25B | 51.5% |
Mar 2024 | 4288398000 | 2.22B | 51.78% |
Jun 2023 | -1.47M | -17.60M | -5.89M |
---|---|---|---|
Sep 2023 | 35.16M | -24.50M | -6.39M |
Dec 2023 | 91.26M | -30.65M | -7.84M |
Mar 2024 | 45.79M | -17.86M | -26.84M |
ICU Medical alternative data
Aug 2023 | 14,500 |
---|---|
Sep 2023 | 14,500 |
Oct 2023 | 14,500 |
Nov 2023 | 14,500 |
Dec 2023 | 14,500 |
Jan 2024 | 14,500 |
Feb 2024 | 14,500 |
Mar 2024 | 14,000 |
Apr 2024 | 14,000 |
May 2024 | 14,000 |
Jun 2024 | 14,000 |
Jul 2024 | 14,000 |
ICU Medical other data
Period | Buy | Sel |
---|---|---|
Feb 2024 | 0 | 1660000 |
Mar 2024 | 0 | 71983 |
May 2024 | 0 | 14839 |
Aug 2024 | 0 | 16552 |
Sep 2024 | 0 | 12000 |
Oct 2024 | 0 | 12000 |
Nov 2024 | 0 | 24083 |
Dec 2024 | 0 | 14241 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | WOOLSON DANIEL officer: VP, GM-Infusion Capital | Common Stock | 2,241 | $156.25 | $350,158 | ||
Option | JAIN VIVEK director, officer.. | Common Stock | 12,000 | $88.76 | $1,065,120 | ||
Sale | JAIN VIVEK director, officer.. | Common Stock | 3,672 | $162.29 | $595,922 | ||
Sale | JAIN VIVEK director, officer.. | Common Stock | 8,250 | $163.18 | $1,346,227 | ||
Sale | JAIN VIVEK director, officer.. | Common Stock | 78 | $163.96 | $12,789 | ||
Option | JAIN VIVEK director, officer.. | Non-Qualified Stock Option (right to buy) | 12,000 | $88.76 | $1,065,120 | ||
Option | GREENBERG DAVID C. director | Common Stock | 972 | $94.68 | $92,029 | ||
Sale | GREENBERG DAVID C. director | Common Stock | 972 | $158.11 | $153,683 | ||
Option | GREENBERG DAVID C. director | Non-Qualified Stock Option (right to buy) | 972 | $94.68 | $92,029 | ||
Option | VOIGTLANDER CHRISTIAN B. officer: Chief Op.. | Non-Qualified Stock Option (right to buy) | 1,430 | $96.83 | $138,467 |
Patent |
---|
Grant Filling date: 29 May 2020 Issue date: 13 Sep 2022 |
Grant Filling date: 28 May 2019 Issue date: 13 Sep 2022 |
Grant Filling date: 22 Jun 2020 Issue date: 6 Sep 2022 |
Grant Filling date: 21 Nov 2019 Issue date: 6 Sep 2022 |
Grant Utility: Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system Filling date: 27 Dec 2018 Issue date: 6 Sep 2022 |
Application Filling date: 17 Feb 2022 Issue date: 25 Aug 2022 |
Grant Filling date: 28 Aug 2019 Issue date: 2 Aug 2022 |
Grant Filling date: 27 Apr 2020 Issue date: 26 Jul 2022 |
Application Filling date: 31 Mar 2022 Issue date: 21 Jul 2022 |
Grant Filling date: 21 Dec 2017 Issue date: 19 Jul 2022 |
Quarter | Transcript |
---|---|
Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 27 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
Edwards Lifesciences: Rising Dominance In Structural Heart Disease
ICU Medical: Continued Disappointments
Bausch + Lomb: Still A Favorable Risk-To-Reward Prospect
ICU Medical: Recent Breakout Piques Interest, But Lacks Supporting Market Data
Bausch + Lomb: Shares Deserve Some Upside
ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value
STAAR Surgical: Drastically Overpriced
-
What's the price of ICU Medical stock today?
One share of ICU Medical stock can currently be purchased for approximately $123.76.
-
When is ICU Medical's next earnings date?
Unfortunately, ICU Medical's (ICUI) next earnings date is currently unknown.
-
Does ICU Medical pay dividends?
No, ICU Medical does not pay dividends.
-
How much money does ICU Medical make?
ICU Medical has a market capitalization of 3.74B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.92% to 2.26B US dollars.
-
What is ICU Medical's stock symbol?
ICU Medical, Inc. is traded on the NASDAQ under the ticker symbol "ICUI".
-
What is ICU Medical's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of ICU Medical?
Shares of ICU Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ICU Medical's key executives?
ICU Medical's management team includes the following people:
- Mr. Vivek Jain Chief Executive Officer & Chairman(age: 53, pay: $1,310,000)
- Mr. Brian Michael Bonnell Chief Financial Officer & Treasurer(age: 51, pay: $726,990)
- Mr. Christian B. Voigtlander Chief Operating Officer(age: 56, pay: $684,830)
- Ms. Virginia Ruth Sanzone Corporation Vice President, Gen. Counsel, Sec. & Compliance Officer(age: 50, pay: $492,820)
-
How many employees does ICU Medical have?
As Jul 2024, ICU Medical employs 14,000 workers.
-
When ICU Medical went public?
ICU Medical, Inc. is publicly traded company for more then 33 years since IPO on 31 Mar 1992.
-
What is ICU Medical's official website?
The official website for ICU Medical is icumed.com.
-
Where are ICU Medical's headquarters?
ICU Medical is headquartered at 951 Calle Amanecer, San Clemente, CA.
-
How can i contact ICU Medical?
ICU Medical's mailing address is 951 Calle Amanecer, San Clemente, CA and company can be reached via phone at +94 93662183.
-
What is ICU Medical stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for ICU Medical in the last 12 months, the avarage price target is $190.5. The average price target represents a 53.92% change from the last price of $123.76.
ICU Medical company profile:

ICU Medical, Inc.
icumed.comNASDAQ
14,000
Medical - Instruments & Supplies
Healthcare
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
San Clemente, CA 92673
CIK: 0000883984
ISIN: US44930G1076
CUSIP: 44930G107